Toward risk-adjusted CT schedules in first-line metastatic colorectal cancer
{{output}}
To conclude, this study provides a compelling, evidence-based foundation for risk-adjusted follow-up in mCRC, challenging outdated surveillance rhythms. It brings us closer to precision oncology-not in treatment selection this time, but in monitoring strategy.... ...
